Markets
News
Analysis
User
24/7
Economic Calendar
Education
Data
- Names
- Latest
- Prev
- Trade
- Markets
- Copy
- Contests
- News
- 24/7
- Calendar
- Q&A
- Chats
Trending
SYMBOL
LAST
BID
ASK
HIGH
LOW
NET CHG.
%CHG.
SPREAD
SPX
S&P 500 Index
6800.25
6800.25
6800.25
6819.26
6759.73
-16.26
-0.24%
--
DJI
Dow Jones Industrial Average
48114.25
48114.25
48114.25
48452.17
47946.25
-302.30
-0.62%
--
IXIC
NASDAQ Composite Index
23111.45
23111.45
23111.45
23162.60
22920.66
+54.05
+ 0.23%
--
USDX
US Dollar Index
98.160
98.240
98.160
98.160
97.790
+0.260
+ 0.27%
--
EURUSD
Euro / US Dollar
1.17075
1.17083
1.17075
1.17520
1.17075
-0.00392
-0.33%
--
GBPUSD
Pound Sterling / US Dollar
1.33725
1.33732
1.33725
1.34265
1.33718
-0.00482
-0.36%
--
XAUUSD
Gold / US Dollar
4326.56
4327.64
4326.56
4342.37
4301.37
+24.27
+ 0.56%
--
WTI
Light Sweet Crude Oil
55.952
55.989
55.952
56.055
54.927
+1.013
+ 1.84%
--
- All
- Chatrooms
- Groups
- Friends
Connecting
.
.
.
- All
- Russia-Ukraine Conflict
- Middle East Flashpoint
Joinn Laboratories Expects Turn to H1 Profit Despite Drop in Revenue; Shares Decline 6%
MT Newswires
Joinn Laboratories (China) said it expects to turn to profit in the first half of 2025, and report an up to 25% decrease in revenue, according to a Hong Kong bourse filing Monday.
Shares of the pharma research company fell nearly 6% in afternoon trade Tuesday.
The company expects attributable profit of 50.3 million yuan to 75.5 million yuan for the six months ended June 30, compared with a loss of 169.7 million yuan in the same period last year.
Meanwhile, the company expects to report 635.1 million yuan to 702 million yuan in revenue for the period, down 17% to 25% from the 849.4 million yuan a year prior.
Joinn Laboratories expects to post its H1 results by the end of August.
Risk Warnings and Disclaimers
You understand and acknowledge that there is a high degree of risk involved in trading. Following any strategies or investment methods may lead to potential losses. The content on the site is provided by our contributors and analysts for information purposes only. You are solely responsible for determining whether any trading assets, securities, strategy, or any other product is suitable for investing based on your own investment objectives and financial situation.
Copyright © 2025 FastBull Ltd
728 RM B 7/F GEE LOK IND BLDG NO 34 HUNG TO RD KWUN TONG KLN HONG KONG
Risk Disclosure
The risk of loss in trading financial instruments such as stocks, FX, commodities, futures, bonds, ETFs and crypto can be substantial. You may sustain a total loss of the funds that you deposit with your broker. Therefore, you should carefully consider whether such trading is suitable for you in light of your circumstances and financial resources.
No decision to invest should be made without thoroughly conducting due diligence by yourself or consulting with your financial advisors. Our web content might not suit you since we don't know your financial conditions and investment needs. Our financial information might have latency or contain inaccuracy, so you should be fully responsible for any of your trading and investment decisions. The company will not be responsible for your capital loss.
Without getting permission from the website, you are not allowed to copy the website's graphics, texts, or trademarks. Intellectual property rights in the content or data incorporated into this website belong to its providers and exchange merchants.
Not Logged In
Log in to access more features
FastBull Membership
Not yet
Purchase
Become a signal provider
Help Center
Dark Mode
Price Up/Down Colors
Log In
Sign Up